Catheter based ventriculography has evolved over the last century and in many instances has been replaced by use of cardiac ultrasound. Despite the shift, ventricular function remains an important part of assessing myocardial damage and prognosis. There is no doubt that cardiac ultrasound
can evaluate LV size, myocardial wall motion and wall thickening, and is non-invasive, readily available, relatively inexpensive and portable. Poor acoustic windows are the major limitation of cardiac ultrasound as are foreshortened imaging planes. In contrast, catheter based left ventriculography,
can evaluate similar attributes of LV function but limitations are that it is invasive requiring arterial access, involves radiation exposure, and the use of iodinated radio-opaque contrast which may result in renal dysfunction. The Society of Cardiovascular angiography and Intervention (SCAI)
recommendations for catheter based left ventriculography are consensus opinions which need rigorous prospective evaluation. Probably the most important SCAI recommendation is that local criteria should be developed to decrease variation in performance among operators within individual catheterization
laboratories. No data are available to determine which patient gets catheter based left ventriculography or echo assessment of ventricular function. Decision making regarding the use of catheter based or ultrasound based angiography is quite complex because of limitation and interaction of
the various determinants, e.g. creatinine, diabetes, gender, contrast volume and fluoro time.
No References for this article.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: April 1, 2019
This article was made available online on June 13, 2018 as a Fast Track article with title: "Ventriculography in a Single Catheterization Laboratory".
More about this publication?
Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites